Ulrich Niedballa
Schering AG
87 Papers
592 Citations
Ulrich Niedballa is an academic researcher from Schering AG. The author has contributed to research in topics: Alkyl & Oligonucleotide. The author has an hindex of 13, co-authored 87 publications. Previous affiliations of Ulrich Niedballa include Bayer HealthCare Pharmaceuticals.
Chat about Author
Papers
Patent
DTPA di-alkyl monoamides for x-ray and MRI
Johannes Platzek,Ulrich Niedballa,Peter Mareski,Bernd Radüchel,Hanns-Joachim Weinmann,Andreas Dr Muehler,Bernd Misselwitz +6 more
- 07 Jun 1995
TL;DR: In this article, the authors described the use of diethylenetriamine pentaacetic acid monoamide derivatives, their complexes and complex salts, containing gadolinium, dysprosium, iron or manganese, as contrast media and process for their production.
2
Patent
New aromatic-substituted tetraazacyclododecane-triacetic acid paramagnetic metal complex compounds, are useful as contrast agents for magnetic resonance imaging of necrotic or infarction tissue
Johannes Platzek,Heribert Schmitt-Willich,Ulrich Niedballa,Wolfgang Ebert,Hanns-Joachim Weinmann +4 more
- 13 Jan 2000
TL;DR: Polycyclic aromatic-substituted 1,4,7,10-tetraazacyclodecane-1, 4,7-triacetic acid metal complex derivatives of formula Ar-(L-K)n (I) are new.
1
Patent
Use of metal complexes containing perfluoroalkyl as contrast agents in magnetic resonance imaging for representing intravascular thrombi
Bernd Misselwitz,Johannes Platzek,Yoko Kawata,Hanns-Joachim Weinmann,Takishi Yokawa,Ulrich Niedballa +5 more
- 05 Jul 2003
TL;DR: In this article, the use of metal complexes containing perfluoroalkyl as contrast agents in MR imaging for representing intravascular thrombi was proposed, which has a critical micelle-formation concentration 1 nm and a proton relaxivity in plasma (R1) > 10 l/mmol.s.
1
Patent
Porphyrin derivatives and their use in photodynamic therapy and mri diagnosis
Johannes Platzek,Ulrich Niedballa,Bernd Radüchel,Hanns-Joachim Weinmann,Thomas Frenzel,Wolfgang Ebert +5 more
- 17 Jun 1999
TL;DR: In this article, the use of porphyrin complexes for photodynamic therapy and MRI diagnosis has been discussed, and new porphrin-complex compounds, drug products containing same, and their preparation for the preparation of products for photodynamics.
1
Patent
13,17-Propionsäure- und Propionsäurederivat-substituierte Porphyrin-Komplexverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
Ulrich Niedballa,Gries Heinz,Jurgen Conrad,Niedballa Ulrich Dr +3 more
- 11 Aug 1989
TL;DR: Porphyrin-Komplexverbindungen, bestehend aus mindestens einem Porphrinligan-den, gegebenenfalls mindestENS einem Ion eines Elements der Ordnungszahlen 5, ��13, 21-32, 37-39, 42-44, 49, 50 oder 57-83, sind anoríganischer und/oder organischer Basen, Aminosauren oder Aminosaureamide, s. as discussed by the authors.
1